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RESEARCH ARTICLE
Characterization of glycoproteins by capillary electrophoresis 
electrospray mass spectrometry (CE-ES-MS). Applications 
to diagnosis in biomedicine
Summary
Characterization of Glycoproteins by Capillary
Electrophoresis Electrospray Mass Spectrometry
(CE-ES-MS). Applications to Diagnosis in Biomedicine
Glycosylation is the most common posttranslational modification 
in proteins and the carbohydrates participate in many biological 
processes. The number and type of glycoforms for a certain 
glycoprotein may change as a consequence of pathological processes. 
In our work a method for the separation of transferrin sialoforms 
has been developed, that permits the diagnostic of Congenital 
Disorders of Glycosylation (CDG) using a polybrene-dextran 
sulphate coating and CE-ESI-TOF methodologies. In order to 
improve the sensitivity the use of solid-phase extraction coupled 
 on-line to CE-ESI-MS is studied and the SPE-CE-ESI-MS 
developed methods are applied for the characterization of rHuEPO 
glycoforms. The achieved separation and the high mass-resolving 
power of flight (TOF)  mass detection allows to establish the most 
probable rHuEPO glycoforms.
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INTRODUCTION
Genomics and, even more important, the wide field 
of proteomic and related clinical applications like 
biomarkers, dramatically increase the demand of 
sensitive and selective analytical tools for the analysis 
of biological samples. The sugar content of proteins 
has been demostrated to be critical for its biological 
activity, and it is influenced during its manufacturing 
process by the cell line and the incubation culture 
conditions1. The polymorphism associated with the 
amount, the size, and the structur e of the carbohydrate 
chains is known as microheterogeneity, and the mo-
lecular species generated ar e termed glycoforms. In 
this context, investigations of glycoproteins have 
become increasing important, in particular with re-
spect to the variations in glycosylation patterns ob-
served in serum from healthy individuals and patiens. 
Glycosylation is the most common posttranslational 
modification in proteins and carbohydrates participate 
in many biological processes and encode information
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for molecular recognition, protein folding, stability 
and pharmacokinetics2. The number and type of 
glycoforms for a certain glycoprotein may change as 
a consequence of pathological processes3 . For example, 
patients with Congenital Disor ders of Glycosylation 
(CDG) or chronic alcoholism present hypoglycosyla-
tion of several plasmatic glycoproteins as transferrin 
(Tf), which is analyzed as a model glycoprotein for 
CDG diagnosis4. Tf is one of the twenty high abun-
dance human plasma proteins. Other different ana-
lytical problem is analysis of erythropoietin (EPO) 
which is found as very low abundance protein. EPO 
is a glycoprotein hormone, which regulates erythro-
poiesis and has been extensively used for the treatment 
of several anemias associated with acute and chronic 
diseases5. Despite the many benefits of EPO in the 
clinic, it has been most widely publicized on account 
of its extensive misuse as performance enhancing 
agent in endurance sports6.
Until recently, isoelectric focusing electrophoresis was 
the reference method for glycoforms analysis due to 
its high selectivity allowing an easy detection of 
genetic glycoprotein variants. However, this complex 
and time consuming procedure favoured the intro-
duction of new alternative methods. Capillary elec-
trophoresis (CE), has become one of the most impor-
tant techniques for glycoform separation7. In previous 
studies Tf sialoforms were resolved by CE-UV 4. Also 
the two commercial ready-to-use pharmaceuticals of 
recombinant human EPO (rHuEPO), epoetin-α and 
epoetin-β, and the hyperglycosylated EPO analogue 
NESP was analysed8, 9 . Separation and characteriza-
tion of the different glycoforms from each glycoprotein 
are presented. However endogenous EPO are gener-
ally found at subnanomolar levels such as other 
endogenous hormones and the poor concentration 
detection sensitivity of CE precludes the direct analysis 
of these hormones at the levels found in biological 
fluids.
The high values of the concentration limits of detection 
in CE are closely related with the small volume ca-
pacity of the capillary columns. Several instrumental, 
electrophoretic and chromatographic modifications 
have been described in order to overcome this limi-
tation. In solid phase extraction coupled on-line to 
capillary electrophoresis (SPE-CE), a microcartridge 
or analyte concentrator is inserted near the inlet of 
the separation capillary10. The analyte concentrator 
contains a solid phase extraction sorbent which retains 
the target analyte, enabling large volumes of sample 
to be intruduced. The captured analyte is eluted in a 
small volume of an appropiate solution, resulting in 
sample clean-up and concentration enhancement, 
with minimum sample handling. Several researchers 
have perceived the suitability of SPE-CE to perform 
selective and sensitive analysis of proteins and pep-
tides in complex diluted samples. In addition, the use 
of solid-phase extraction coupled on-line to capillary 
electrophoresis electrospray mass spectrometry (SPE-
CE-ESI-MS) has demonstrated improved capabilities 
for characterization of compounds found at low con-
centration in a complex matrix10.
Mass spectrometry (MS) has emerged as a powerful 
tool for the analysis of large biomolecules. However, 
direct analysis of intact glycoproteins by MALDI-
TOF and conventional electrospray ionization mass 
spectrometry (ESI-MS) has presented some problems 
in order to resolve microheterogenous structures. 
Thus, a previous glycoform separation is mandatory 
to obtain valuable information about the carbohydrate 
heterogeneity of glycoproteins. CE-ESI-MS has been 
successfully used for this purpose. 11-13. However, 
volatile background electrolytes (BGE) are necessary 
to provide suitable electrospray ionization and there-
fore, obtain good sensitivity. The non-volatile BGE 
used in the current CE-UV methods for glycoform 
separation preclude the CE-ESI-MS coupling 14-16.
In our work, CE-UV methods for the separation of 
glycoforms in volatile BGE have been developed. The 
CE-ESI-MS separation method for intact rHuEPO has 
been improved as a consequence of the use of a novel 
acrylamide-based coating that provides a stable sup-
pression of electroosmotic flow (EOF) and allows a 
succesful glycoform separation7, 17 Also a method for 
the separation of Tf sialoforms has been developed, 
that permits the diagnostic of Congenital  Disorders 
of Glycosylation and chronic alcoholism. A negative 
modified capillary is obtained by a first amino qua-
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ternary coating (Polybrene) attached to the capillary 
wall, followed by a second anionic coating (Dextran 
sulphate)6, 7. In order to improve detection limits of 
CE-ESI-MS methodologies, the use of solid-phase 
extraction coupled on-line to capillary electrophoresis 
using electrospray mass spectrometry detection (SPE-
CE-ESI-MS) is studied for the analysis of peptide 
hormones in dilute solutions10. This resulted in sample 
clean-up and concentration enhancement, with min-
imum sample handling. The CE-ESI-MS developed 




All chemicals used in the preparation of buffers and 
solutions are analytical reagent grade. Standard hu-
man transferrin (partially saturated, min 98%), insulin, 
sodium dextran sulphate (M=500000), and hexa-
dimethrin bromide (Polybrene, PB, M=15000) are 
purchased from Sigma Ultra Tol™ Dynamic PreCoat 
LN was provided by Target Discovery (Palo Alto, 
CA, USA). Trypsin Gold, Mass Spectrometry Grade, 
was obtained by Promega (Madison, WI, USA). Stan-
dard rHuEPO was obtained as BRP from Pharmaco-
poeia (EDQM, European Pharmacopoeia, Council of 
Europe, Strasbourg, France). Epoetin-α (Eprex) 6000 
IU from Janssen-Cilag (Neuss, Germany) and epoe-
tin-β (NeoRecormon) 4000 IU from Roche (Mannheim, 
Germany) were obtained as ready-to-use drugs. Deio-
nised and organic-eliminated water was obtained 
using a Milli-Q water purification system (Millipore, 
Schwalbach, Germany). All solutions and background 




CE analysis was performed on a Hewlett Packard CE 
(Agilent Technologies, Waldbronn, Germany). For 
CE-ESI-MS coupling, a coaxial sheath-liquid sprayer 
was used (Agilent Tecnologies). For intact EPO gly-
coprotein analysis, separation was performed in cap-
illaries coated with polybren (PB) or ultra Tol™ Dy-
namic Pre-Coat LN (LN). For Tf analysis  the 
separation capillary is coated with a polybren-dextran 
sulphate (PB-DS) double layer coating.
MS 
Mass spectrometric Tf analysis is carried out in a 
Mariner TOF mass spectrometer (Perseptive Biosys-
tems, Framingham, MA, USA) coupled to the CE 
system, whereas the hormone spectrometric investi-
gations an EPO characterization are performed with 
the CE system coupled to a MSD Ion Trap mass 
spectrometer (Agilent Technologies) and an orthogo-
nal accelerated TOF mass spectrometer (oaTOF-MS) 
(MicroTOF, Bruker Daltonik), respectively.
RESULTS AND DISCUSSION
Transferrin glycoform analysis by CE-UV and CE-
ESI-MS. Application to CDG chronic alcoholism di-
agnosis.
A CE-UV separation method has been developed 
using a MS compatible buffer with 25 mM NH4Ac at 
pH 8.5. Best separation conditions have been obtained 
in a coated capillary based on a Successive Multiple 
Ionic Layer (SMIL) performed by a first layer of PB 
and a second layer of dextran-sulphate (DS). This 
coating provides a constant and cathodic EOF, and 
minimizes the interactions between Tf and capillary 
walls. 
In order to deplete albumin and the most abundant 
immunoglobulins from serum, a commercial kit based 
on dyes and immunoaffinity capture has been used 
prior to electrophoretic analysis. Figure 1 shows the 
obtained electropherograms in two different sera, one 
from a healthy individual and the other from a CDG 
patient. A clear difference on the electrophoretic 
profiles is observed. The CE-UV developed method 
is now applied in clinical diagnosis.
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Using CE-ESI-MS methodologies the best sensitivity 
is obtained with a sheath liquid containing 90% of 
methanol and 0.5 % formic acid. Other experimental 
parameters as sheath liquid flow rate, nebulizer gas 
and ionization potentials have been optimized in 
order to achieve good sensitivity and separation. 
Separation of different proteins present in serum has 
been achieved and mass spectra can be deconvoluted. 
A glycoform of 77387 Da is obtained in a serum from 
a CDG patient that is not observed for a control serum 
(Figure 2).
Analysis of hormones by on line SPE-CE-ESI-MS
Endogenous hormones are generally found at subna-
nomolar levels in biological samples. In our studies, 
solid-phase extraction coupled on-line to capillary 
electrophoresis electrospray mass spectrometry (SPE-
CE-ESI-MS) is explored for the preconcentration and 
separation of dilute solutions of  peptide hormones. 
First, a CE-ESI-MS methodology is developed and 
validated. Limits of detection (LOD) of around 1 µg 
mL  are obtained for all the studied hormones. For 
SPE-CE-ESI-MS experiments, a home-made SPE mi-
crocartridge containing a C18 sorbent is constructed 
near the inlet of the separation capillary. (Figure 3). 
After optimizing the on-line preconcentration meth-
odology, LOD between 0.1 and 10 ng mL-1 are 
achieved. The preconcentration methodologies have 
been applied to rHuEPO analysis using an on-line 
inmunoaffinity solid phase extraction (IA-CE-ESI-
MS).The preliminary results obtained using a custom-
made inmunoaffinity sorbent prepared from an anti-
human EPO polyclonal antibody and glutaraldehyde-
glass beads show the potential of this novel approach.
Characterization of rHuEPO glycoforms by CE-ESI-
MS
Several recombinant human erythropoietins (rHuE-
PO) from different origin have been analysed. Coated
Figure 1.	 CE-UV electropherograms obtained from different 		
serum samples. a) Non-treated healthy, b) healthy 		
serum and c) CDG serum both passed through the 		
albumin depletion kit.
Figure 2.	 a) Total Ion Electropherogram obtained from a serum 	
from a healthy individual in the CE-ESI-MS optimized 	
conditions. b) and c) deconvoluted mass spectra 			
obtained from the beginning and the end of the Tf 		
peak respectively. d) Total Ion Electropherogram 			
obtained for a serum from a CDG patient. e) and f) 		
deconvoluted mass spectra obtained from the two 		
partial resolved glycoforms of Tf. The most probable 	
glycan composition is displayed below the 			
deconvoluted mass spectra.
Figure 3.	 Scheme of a cartridge containing a capillary column 		
with a C18 analyte concentrator (C18 AC) for SPE-CE-	
UV analysis.
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capillaries are mandatory in order to decrease or 
suppress the adsorption of glycoproteins to the silica 
capillary wall. In our works, two different capillary 
coatings have been used: 1 polybrene (PB), an amino 
quaternary polymer with positive charges that revers-
es the EOF, and2 UltraTol Dynamic Pre-Coat Low 
Normal (LN), an acrylamide polymer that suppresses 
the EOF at low pH. The best sensitivity has been 
obtained with sheath liquids containing 1% acetic 
acid and high resolution TOF-MS has been found to 
be the most suitable mass analyzer for detection of 
intact glycoproteins differing in a few Da. In CE-ESI-
MS analyses of intact glycoproteins, numerous and 
complex data are obtained and therefore, extracting 
useful and valuable information from spectra is not 
as obvious as in more straightforward compounds. 
Figure 4 shows the separation and mass spectra ob-
tained from rHuEPO in a LN coated capillary, sum-
marizing the procedure performed in the data analysis.
In order to obtain a more complete information about 
the carbohydrate moiety of glycoproteins, a study of 
the composition and structure of the glycans is nec-
essary. In our work a CE-ESI-MS separation method 
has been developed for the analysis of the  N-glycans 
obtained by PNGase F release from the glycoproteins 
(Figure 5). Also the sialic acid content of the O-
glycosylation site has been characterized based on 
the glycopeptides obtained by trypsin digest and CE-
ESI-MS analysis. Therefore, the probability of every 
intact sialoform has been calculated taking into ac-
count the number of glycosylation sites, and the 
percentages of the N-glycans and the O-glycans de-
pending on their sialic acid content. The data have 
been compared with the normalized areas obtained 
from the EIE of the intact sialoforms of Pharmacopoeia 
rHuEPO, and therefore the sialic acid assignment has 
been performed. Once sialic acid number has been 
assigned, a global carbohydrate composition is de-
duced in high confidence. Thus, a main molecular 
mass of 29888.2 Da, consists of the protein backbone 
(165 amino acids, 18235.8 Da), 22 hexoses, 19 N-
acetylhexosamines, 3 fucoses and 13 sialic acids (Figure 
6). Table 1 shows the main observed molecular masses 
and the respective carbohydrate composition.
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Figure 4.	 Schematic view for data processing of intact CE-ESI-		
MS glycoprotein analysis in a LN coated capillary, 		
BGE: 2M acetic acid, separation voltage + 30kV. Sample: 	
Pharmacopoeia rHuEPO 2.5  g/ L injected for 15s, at 	
50 mbar. a) Base Peak Electropherogram (BPE) obtained, 	
b) mass spectrum obtained in 25.0-25.2 min, c)  			
deconvoluted mass spectrum, d) ion identification for 	
29888.2 Da glycoform, e) Extracted Ion 			
Electropherogram (EIE) obtained for 29888.2 Da 			
glycoform (in purple) and for some of the different 		
sialoforms present in rHuEPO (in grey).
Figure 5.	 Typical tetra-antennary N-glycan of rHuEPO.
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CONCLUSIONS
A  CE-ESI-MS method for the separation of Tf glyco-
forms has been developed, that permits the diagnostic 
of CDG and chronic alcoholism. The method uses a 
SMIL coated capillary  performed by a first layer of 
polybrene and a second layer of dextran and a sheath 
liquid interface containing 90 % of methanol and 0,5 
% formic acid. Also, solid-phase extraction coupled 
on-line to capillary electrophoresis electrospray mass 
spectrometry (SPE-CE-ESI-MS) is explored in order 
to improve sensitivity of the method. LOD between 
10 and 0,1 ng mL  are achieved using an on-line 
preconcentrator. All these methodologies are applied 
for characterization of intact rHuEPO glycoforms. 
Numerous and complex data are obtained and there-
fore a study of the composition and structure of the 
N-glycans, obtained by PNGase F digestion, is neces-
sary. Also the sialic acid content of O-glycosylation 
site has been characterized based on the glycopeptides 
obtained by trypsin digest and CE-ESI-MS analysis. 
Therefore, the probability of every intact sialoform 
has been calculated taking into account the number 
of glycosylation sites, and the percentages of the N-
glycans and the O-glycans depending on their sialic 
acid content. The data have been compared with the 
normalized areas obtained from the EIE of the intact 
sialoforms, and therefore the sialic acid assignment 
has been performed. Once sialic acid number has 
been assigned, a global carbohydrate composition is 
deduced in high confidence. Thus, for example, a 
main molecular mass of 29888.2 Da,  consists of the 
protein backbone (165 amino acids, 18235.8 Da), 22  
Hexoses, 19 N-acetylhexosamines, 3 fucoses and 13 
sialic acids.
Figure 6.	 One possible glycan composition for an intact rHuEPO 	
glycoform of 29888.2 Da containing 22 hexoses (Ο), 19 	
N-acetylhexosamines (®), 3 fucoses (_) and 13 sialic 		
acids (♦).
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